Firms
Theme

HII

Huntington Ingalls Industries, Inc. · NYSE

News

15 latest

Zacks Investment Research

Can AUKUS Submarine Demand Support HII's Long-Term Growth?

Huntington Ingalls Industries (HII) secured a $56 million U.S. Navy contract for submarine design and engineering support under the AUKUS partnership, with potential to reach $91 million. The contract leverages HII's nuclear shipbuilding expertise to support submarine design, technology integration, and supply-chain development among the United States, United Kingdom, and Australia. HII's stock trades at a discount relative to its industry peers, and analyst estimates for 2026-2027 earnings have improved.

Zacks Investment Research

5 Low Price-to-Book Stocks to Watch for Growth Potential in October

The article identifies five stocks trading below their book value with strong growth prospects: Banco Macro (26.6% projected EPS growth), Avnet (31.3%), EnerSys (15.0%), General Motors (13.3%), and Huntington Ingalls Industries (14.4%). All five stocks have Value Scores of A or B and Zacks Ranks of #1 or #2, suggesting they are undervalued with upside potential.

GlobeNewswire Inc.

USS Harry S. Truman (CVN 75) Arrives at HII’s Newport News Shipbuilding to Start its Refueling and Complex Overhaul

USS Harry S. Truman (CVN 75) arrived at HII's Newport News Shipbuilding on September 30, 2026, to begin its refueling and complex overhaul (RCOH). The project represents a major mid-life maintenance and modernization effort for the eighth Nimitz-class carrier to undergo this availability. HII was awarded a $5.1 billion contract to execute the work, which includes hull repairs, propeller maintenance, and nuclear refueling.

Zacks Investment Research

HII or SAFRY: Which Is the Better Value Stock Right Now?

A comparison of two aerospace-defense stocks reveals that Huntington Ingalls (HII) presents a more attractive value opportunity than Safran SA (SAFRY). HII has a Zacks Rank of #2 (Buy) with improving earnings outlook, a forward P/E of 14.06, and a Value grade of B. SAFRY has a Zacks Rank of #3 (Hold) with a forward P/E of 32.93 and a Value grade of D, making it significantly more expensive on traditional valuation metrics.

GlobeNewswire Inc.

HII Wins U.S. Navy Contract for 10 ROMULUS USVs, Accelerating Deployment of Proven Autonomous Capability

HII has been awarded a U.S. Navy contract to build 10 ROMULUS unmanned surface vessels (USVs) for the Medium Unmanned Surface Vessel (MUSV) program. The contract marks a significant milestone in transitioning autonomous maritime systems from experimentation to fleet-scale operational deployment. HII is leveraging its Odyssey Autonomous Control Solutions and a distributed production model with regional Gulf Coast partners to deliver the vessels at scale.

Mentions HII

Zacks Investment Research

General Dynamics (GD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

General Dynamics is expected to report Q3 2026 earnings of $4.14 per share (up 6.7% YoY) with revenues of $13.69 billion (up 6% YoY) on October 30. The company has a positive Earnings ESP of +0.77% combined with a Zacks Rank #3, suggesting it will likely beat consensus estimates. General Dynamics has beaten EPS estimates in all four trailing quarters.

Zacks Investment Research

Lockheed Q3 Earnings Beat Estimates, Sales Increase Year Over Year

Lockheed Martin reported Q3 2026 adjusted EPS of $7.97, beating consensus estimates by 6.4%, with sales climbing 11.3% to $20.71 billion. The company's backlog surged to $291.98 billion, driven by strong performance in Missiles and Fire Control (up 24% YoY). LMT raised its 2026 full-year sales guidance to $80-$82 billion and adjusted EPS outlook to $30.35-$30.75.

Zacks Investment Research

Hexcel Q3 Earnings Surpass Estimates, Revenues Improve Y/Y

Hexcel Corporation (HXL) reported Q3 2026 adjusted EPS of 50 cents, up 35.1% year-over-year and beating consensus estimates. Net sales grew 8.8% to $496.4 million, driven by a 20.5% surge in Commercial Aerospace sales from Airbus and Boeing programs. The company raised 2026 guidance to $2.03-$2.13 billion in sales and $2.30-$2.40 in adjusted EPS, with free cash flow expected above $195 million.

Zacks Investment Research

Is BWXT a Buy as Nuclear Growth Meets Execution and Valuation Risk?

BWX Technologies is expanding in defense and commercial nuclear markets with $1.4 billion in naval contracts and raised 2026 guidance to $3.80 billion revenue. However, the stock trades at a 27.10X forward P/E near its five-year median, leaving limited room for execution errors. Margin pressure in commercial operations and concentration of earnings in Q4 present risks, warranting a balanced approach.

Zacks Investment Research

BWXT Falls 19.8% in 3 Months: Does the Pullback Create Opportunity?

BWX Technologies shares have declined 19.8% over three months despite 18% revenue growth, a $8.4 billion backlog (up 40% YoY), and raised 2026 guidance. While the pullback improves valuation to 27.10X forward earnings, execution risks remain due to margin pressure, capital intensity in commercial operations, and Q4-heavy earnings concentration.

Zacks Investment Research

BWXT Raises 2026 Guidance as Commercial Nuclear Growth Accelerates

BWX Technologies raised its 2026 revenue outlook to $3.80 billion and adjusted EPS guidance to $4.70-$4.80 following strong Q2 results. Commercial revenues surged 71.7% to $302.5 million, driving full-year growth forecast to 45%. However, the company faces execution risks with 55% of second-half earnings concentrated in Q4 and increased capital spending pressuring Commercial margins.

The Motley Fool

$2.9 Billion Contract in Hand, Anduril May Already Be America's Second-Biggest Navy Warship Builder

Anduril Industries, a private defense contractor founded by Oculus inventor Palmer Luckey, has secured a $2.9 billion U.S. Navy contract to build submarine components and plans to invest $3.7 billion in a new 2 million-square-foot shipyard near Baltimore. The move positions Anduril as a potential rival to incumbent submarine builders Huntington Ingalls and General Dynamics, while leveraging its existing autonomous submarine business to potentially become America's most important military shipbuilder.

Zacks Investment Research

Can AeroVironment Expand Its Role in Naval Mine-Countermeasure Systems?

AeroVironment's VideoRay subsidiary was selected to support an AEVEX-led team for a U.S. Navy mine-countermeasure modernization prototype. VideoRay demonstrated autonomous underwater operations launched from an uncrewed surface vessel during competitive testing. The development builds on a $92.6 million Navy contract awarded in 2024 for production and development of the Defender platform.

Zacks Investment Research

Red Cat's USV Mix: Could Blue Ops Accelerate Margin Gains in H2?

Red Cat Holdings (RCAT) expects gross margins to reach ~30% by end-2026 as its Blue Ops maritime division scales production of Variant 7 uncrewed surface vessels (USVs). Blue Ops moved into mass production in Q2 2026 and could achieve profitability by year-end. However, RCAT faces intensifying competition from established players like Huntington Ingalls and Textron, with the stock down 24.9% in the past month and holding a Zacks Rank #4 (Sell) rating.

Zacks Investment Research

Can BWXT's Technical Talent Support Long-Term Nuclear Growth?

BWX Technologies is investing in workforce development with approximately 10,400 employees globally to support its expanding nuclear operations. The company offers competitive compensation, professional training, mentoring, tuition support, and leadership development programs.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $HII · 0 threads

Sign in to post on $HII

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev